Jean-Louis Mège Selected Research

Lipoid Proteinosis of Urbach and Wiethe (Lipoidproteinosis)

2/2021

Granulocyte Macrophage Colony-Stimulating Factor-Specific Autoantibodies and Cerebral Nocardia With Pulmonary Alveolar Proteinosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jean-Louis Mège Research Topics

Disease

5	Infections 02/2021 - 11/2003
2	Whipple Disease (Whipple's Disease) 01/2021 - 11/2018
2	Q Fever (Fever, Q) 11/2019 - 01/2018
2	Endocarditis 11/2019 - 01/2018
2	Thrombosis (Thrombus) 05/2019 - 01/2018
2	Hypersensitivity (Allergy) 01/2019 - 01/2017
2	Cystic Fibrosis (Mucoviscidosis) 01/2018 - 01/2017
2	Sepsis (Septicemia) 01/2018 - 04/2002
2	Bacterial Infections (Bacterial Infection) 01/2016 - 01/2011
2	Granuloma 01/2014 - 08/2010
1	Autoimmune Diseases (Autoimmune Disease) 12/2021
1	Brain Abscess (Abscess, Brain) 02/2021
1	Lipoid Proteinosis of Urbach and Wiethe (Lipoidproteinosis) 02/2021
1	Pulmonary Alveolar Proteinosis 02/2021
1	Disease Progression 01/2021
1	Communicable Diseases (Infectious Diseases) 01/2021
1	Joint Diseases (Joint Disease) 01/2021
1	Leukopenia 01/2021
1	Candidemia 01/2021
1	Arthralgia (Joint Pain) 01/2021
1	Lymphoma (Lymphomas) 05/2020
1	Fibrosis (Cirrhosis) 01/2020
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2020
1	Tuberculosis (Tuberculoses) 05/2019
1	Venous Thrombosis (Deep-Vein Thrombosis) 05/2019
1	Immediate Hypersensitivity 01/2019
1	Delayed Hypersensitivity (Hypersensitivity, Type IV) 01/2019
1	Anaphylaxis (Anaphylactic Shock) 01/2019
1	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 01/2018
1	Hepatitis 01/2018
1	Meningitis 01/2018
1	Cholecystitis 01/2018
1	Allergic Bronchopulmonary Aspergillosis 01/2017
1	Brucellosis (Malta Fever) 01/2016
1	Coinfection 01/2014
1	Hemorrhagic Shock 04/2002
1	Septic Shock (Toxic Shock Syndrome) 04/2002

Drug/Important Bio-Agent (IBA)

4	Immunoglobulin G (IgG)IBA 12/2021 - 01/2017
3	AllergensIBA 01/2019 - 01/2018
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 01/2011
2	Biological ProductsIBA 01/2021 - 08/2010
2	Anticardiolipin AntibodiesIBA 11/2019 - 01/2018
2	AntibodiesIBA 05/2019 - 01/2018
2	Tryptases (Tryptase)IBA 01/2019 - 01/2018
2	Biomarkers (Surrogate Marker)IBA 01/2018 - 01/2017
2	Immunoglobulin E (IgE)IBA 01/2018 - 01/2017
1	AutoantibodiesIBA 02/2021
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 02/2021
1	LactamsIBA 01/2021
1	Tumor Necrosis Factor InhibitorsIBA 01/2021
1	CollagenIBA 01/2020
1	Diethylnitrosamine (N-Nitrosodiethylamine)IBA 01/2020
1	Phospholipids (Phosphatides)FDA LinkGeneric 11/2019
1	Ethanolamine (Colamine)IBA 05/2019
1	AnticoagulantsIBA 05/2019
1	DNA (Deoxyribonucleic Acid)IBA 11/2018
1	HLA-G Antigens (HLA G)IBA 11/2018
1	RNA (Ribonucleic Acid)IBA 11/2018
1	Natriuretic PeptidesIBA 01/2018
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 01/2018
1	landiololIBA 01/2018
1	PrecipitinsIBA 01/2017
1	Arachidonic Acid (Vitamin F)IBA 01/2016
1	LeukotrienesIBA 01/2016
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 01/2016
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2016
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2014
1	Interferon Type IIBA 01/2014
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2011
1	Interferon-gamma (Interferon, gamma)IBA 11/2003
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 04/2002
1	Cell Adhesion MoleculesIBA 04/2002
1	SelectinsIBA 04/2002

Therapy/Procedure

3	Therapeutics 01/2021 - 11/2003
1	Immunotherapy 01/2021
1	Oral Administration 01/2020
1	Microspheres (Microsphere) 01/2014
1	Hip Prosthesis 11/2003